22 results
8-K
EX-2.1
RVLPQ
RVL Pharmaceuticals plc
27 Nov 23
Bankruptcy or Receivership
4:06pm
of, the Court as reasonable, thereby satisfying section 1129(a)(4) of the Bankruptcy Code. The DIP Orders and the applicable engagement letters
8-K
RVLPQ
RVL Pharmaceuticals plc
5 Sep 23
Other Events
4:06pm
to the engagement letter dated August 9, 2023 between the Company and H.C. Wainwright & Co., LLC and the issuance of the Company's ordinary shares upon the exercise
8-K
RVLPQ
RVL Pharmaceuticals plc
25 Aug 23
Regulation FD Disclosure
4:17pm
the Company and an accredited investor and pursuant to the engagement letter dated August 9, 2023 between the Company and H.C. Wainwright & Co., LLC
8-K
EX-4.4
1gq4bx7jnq
18 Aug 23
RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
4:06pm
424B5
g9mr bzbhtxwz181r
17 Aug 23
Prospectus supplement for primary offering
4:05pm
8-K
EX-1.1
86bbe 9n9i
12 Oct 21
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:46pm
424B5
bzqw5c8ksc
8 Oct 21
Prospectus supplement for primary offering
5:13pm
424B5
xxrpnd9vk5vc
6 Oct 21
Prospectus supplement for primary offering
5:25pm
8-K
EX-2.1
xveortg eoe8wmxpe
30 Jun 21
Osmotica Pharmaceuticals plc Announces Conclusion of Strategic Process with Agreement for the Sale of Legacy Business to Alora Pharmaceuticals, LLC
6:04am
8-K
EX-99.1
adbx9446rg6q
1 Jun 21
Jefferies Healthcare Conference June 2021
8:00am
8-K
EX-99.1
4l7mz u219lje
9 Mar 21
Corporate Presentation Barclays Global Healthcare Conference March 2021
10:30am
8-K
EX-99.1
lo11mirpkwv km
20 Dec 19
Management’s Discussion and Analysis of Financial Condition and Results of Operations
4:04pm
10-K
h8wo2wcqr
28 Mar 19
Annual report
12:00am
10-K
EX-4.1
26b85a2g0f5dydp
28 Mar 19
Annual report
12:00am
8-K
EX-99.1
e3f1dvwg7ov32l
4 Dec 18
Regulation FD Disclosure
8:00am
S-1/A
EX-4.1
bkw74y
1 Oct 18
IPO registration (amended)
12:00am
DRS/A
EX-10.25
gj7wv8
13 Jul 18
Draft registration statement (amended)
12:00am
DRS/A
EX-10.24
omornk34ki2wvt2t49f
13 Jul 18
Draft registration statement (amended)
12:00am